Phase I-II study of high-dose busulfan and cyclophosphamide followed by autologous peripheral blood stem cell transplantation for hematological malignancies: toxicities and hematopoietic recovery.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples